You do not have permission to access this chart.
Please Sign Up or Login
News for BELLUS Health Inc. (BLU)
58 minutes ago | Aliexpress.com

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

32

Address:

BELLUS Health Inc. 275 Armand-Frappier Boulevard Laval QC H7V 4A7 Canada

Website:

Home

Phone:

450-680-4500

Leave a comment

Your email address will not be published. Required fields are marked *